Literature DB >> 2264465

Serum carnitine level in phenylketonuric children under dietary control in Greece.

K H Schulpis1, C Nounopoulos, A Scarpalezou, A Bouloukos, S Missiou-Tsagarakis.   

Abstract

Although total, free and esterified carnitine blood levels were found to be low (p less than 0.001) in phenylketonuric patients under dietary treatment compared to controls, no clinical signs of carnitine deficiency were noticed. Exclusion from the PKU diet of nutrients rich in carnitine has been suggested. Supplementation of the diets with carnitine or preferably enrichment of the PKU formulas with carnitine will rectify the restriction of extrinsic carnitine in PKU dietary treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2264465     DOI: 10.1111/j.1651-2227.1990.tb11354.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  11 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

Review 2.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

3.  Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.

Authors:  Bridget M Stroup; Nivedita Nair; Sangita G Murali; Katarzyna Broniowska; Fran Rohr; Harvey L Levy; Denise M Ney
Journal:  J Nutr       Date:  2018-02-01       Impact factor: 4.798

4.  Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.

Authors:  A Sitta; C S Vanzin; G B Biancini; V Manfredini; A B de Oliveira; C A Y Wayhs; G O S Ribas; L Giugliani; I V D Schwartz; D Bohrer; S C Garcia; M Wajner; C R Vargas
Journal:  Cell Mol Neurobiol       Date:  2010-12-30       Impact factor: 5.046

5.  Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia.

Authors:  L Aldámiz-Echevarría; P Sanjurjo; J Elorz; J A Prieto; C Pérez; F Andrade; J Rodríguez-Soriano
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

6.  Inborn errors of metabolism with a protein-restricted diet: effect on polyunsaturated fatty acids.

Authors:  P Sanjurjo; J I Ruiz; M Montejo
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

7.  Polyunsaturated fatty acid status in patients with phenylketonuria.

Authors:  P Sanjurjo; L Perteagudo; J Rodríguez Soriano; A Vilaseca; J Campistol
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

8.  L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Jurema F de Mari; Amanda T Barden; Camila S Vanzin; Giovana B Biancini; Ida V D Schwartz; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2008-09-24       Impact factor: 5.046

9.  Controlled diet in phenylketonuria may cause serum carnitine deficiency.

Authors:  M A Vilaseca; P Briones; I Ferrer; J Campistol; A Riverola; P Castillo; F Ramon
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

10.  Metabolomics of dietary fatty acid restriction in patients with phenylketonuria.

Authors:  Ulrike Mütze; Skadi Beblo; Linda Kortz; Claudia Matthies; Berthold Koletzko; Mathias Bruegel; Carmen Rohde; Joachim Thiery; Wieland Kiess; Uta Ceglarek
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.